본문바로가기

Stem Cell

PR

보도자료, 교육자료, 홍보활동과 공지정보를 안내해드립니다

Article

CLI

Procházka V et al. Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer. Cell Transplant.

2010 ; 19 : 1413-1424.

CLI

Powell RJ et al. Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia. J Vasc Surg.

2011 ; 54 : 1032-1041.

CLI

.Lawall H et al. Treatment of peripheral arterial disease using stem and progenitor cell therapy. J Vasc Surg.

2011 ; 53 : 445-453.

CLI

Kolvenbach R et al. Intraoperative adjunctive stem cell treatment in patients with critical limb ischemia using a novel point-of-care device. Ann Vasc Surg.

2010 ; 24 : 367-372.

CLI

.Klepanec A et al. No difference in intra-arterial and intramuscular delivery of autologous bone marrow cells in patients with advanced critical limb ischemia. Cell Transplant.

2012 ; 21 : 1909-1918.

CLI

Iafrati MD et al. Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia. J Vasc Surg.

2011 ; 54 : 1650-1658.

CLI

Benoit E et al. The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design. J Transl Med.

2011 ; 9 : 165.

CLI

Benoit E et al. Safety and efficacy of autologous cell therapy in critical limb ischemia: a systematic review. Cell Transplant.

2013 ; 22 : 545-562.

CLI

Altaner C et al. Characterization of mesenchymal stem cells of "no-options" patients with critical limb ischemia treated by autologous bone marrow mononuclear cells. PLoS One.

2013 ; 8 : e73722

1